Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation.
Targeting chemoresistant malignant cells is one of the current major challenges in oncology. Therefore, it is mandatory to refine the characteristics of these cells to monitor their survival and develop adapted therapies. This is particularly of interest for acute myeloid leukemia for which 5-year survival rate reach only 30% for all prognosis. The role of microenvironment is increasingly reported to be a key regulator for blast survival. In this context, we demonstrate that contact with mesenchymal stromal cells promote a better survival of blasts in culture in presence of anthracycline through the activation of ABC transporters. Stroma-dependent ABC transporter activation leads to the induction of a side population phenotype in a subpopulation of primary leukemia blasts through Alpha4 engagement. The stroma-promoting effect is reversible and is observed with stromal cells isolated from either healthy donors or leukemia patients. Blasts expressing a side population phenotype are mostly quiescent and are chemoresistant in vitro and in vivo in patient-derived xenograft mouse models. At the transcriptomic level, blats from the side population are specifically enriched in drug metabolism program. This detoxification signature engaged in contact with mesenchymal stromal cells represents promising ways to target stroma-induced chemoresistance of acute myeloid leukemia cells.